Literature DB >> 30632103

Effect of Integrating Substance Use Disorder Treatment into Primary Care on Inpatient and Emergency Department Utilization.

Sarah E Wakeman1,2, Nancy A Rigotti3,4, Yuchiao Chang3,4, Grace E Herman5, Ann Erwin6, Susan Regan3,4, Joshua P Metlay3,4.   

Abstract

BACKGROUND: Components of substance use disorder (SUD) treatment have been shown to reduce inpatient and emergency department (ED) utilization. However, integrated treatment using pharmacotherapy and recovery coaches in primary care has not been studied.
OBJECTIVE: To determine whether integrated addiction treatment in primary care reduces inpatient and ED utilization and improves outpatient engagement.
DESIGN: A retrospective cohort study comparing patients in practices with and without integrated addiction treatment including pharmacotherapy and recovery coaching during a staggered roll-out period. PARTICIPANTS: A propensity score matched sample of 2706 adult primary care patients (1353 matched pairs from intervention and control practices) with a SUD diagnosis code, excluding cannabis or tobacco only, matched on baseline utilization. INTERVENTION: A multi-modal strategy that included forming interdisciplinary teams of local champions, access to addiction pharmacotherapy, counseling, and recovery coaching. Control practices could refer patients to an addiction treatment clinic offering pharmacotherapy and behavioral interventions. MAIN MEASURES: The number of inpatient admissions, hospital bed days, ED visits, and primary care visits. KEY
RESULTS: During the follow-up period, there were fewer inpatient days among the intervention group (997 vs. 1096 days with a mean difference of 7.3 days per 100 patients, p = 0.03). The mean number of ED visits was lower for the intervention group (36.2 visits vs. 42.9 per 100 patients, p = 0.005). There was no difference in the mean number of hospitalizations. The mean number of primary care visits was higher for the intervention group (317 visits vs. 270 visits per 100 patients, p < 0.001). Intervention practices had a greater increase in buprenorphine and naltrexone prescribing.
CONCLUSIONS: In a non-randomized retrospective cohort study, integrated addiction pharmacotherapy and recovery coaching in primary care resulted in fewer hospital days and ED visits for patients with SUD compared to similarly matched patients receiving care in practices without these services.

Entities:  

Keywords:  addiction; buprenorphine; integrated addiction treatment; primary care; recovery coach; substance use disorder; utilization

Year:  2019        PMID: 30632103      PMCID: PMC6544728          DOI: 10.1007/s11606-018-4807-x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  26 in total

1.  Barriers to primary care physicians prescribing buprenorphine.

Authors:  Eliza Hutchinson; Mary Catlin; C Holly A Andrilla; Laura-Mae Baldwin; Roger A Rosenblatt
Journal:  Ann Fam Med       Date:  2014 Mar-Apr       Impact factor: 5.166

2.  Relationship between buprenorphine adherence and health service utilization and costs among opioid dependent patients.

Authors:  Joseph Tkacz; Joseph Volpicelli; Hyong Un; Charles Ruetsch
Journal:  J Subst Abuse Treat       Date:  2013-11-12

3.  Cost and utilization outcomes of opioid-dependence treatments.

Authors:  Onur Baser; Mady Chalk; David A Fiellin; David R Gastfriend
Journal:  Am J Manag Care       Date:  2011-06       Impact factor: 2.229

4.  Extended-release naltrexone for alcohol dependence: persistence and healthcare costs and utilization.

Authors:  William C Bryson; John McConnell; P Todd Korthuis; Dennis McCarty
Journal:  Am J Manag Care       Date:  2011-06       Impact factor: 2.229

5.  Integrating primary medical care with addiction treatment: a randomized controlled trial.

Authors:  C Weisner; J Mertens; S Parthasarathy; C Moore; Y Lu
Journal:  JAMA       Date:  2001-10-10       Impact factor: 56.272

6.  Acute care hospital utilization among medical inpatients discharged with a substance use disorder diagnosis.

Authors:  Alexander Y Walley; Michael Paasche-Orlow; Eugene C Lee; Shaula Forsythe; Veerappa K Chetty; Suzanne Mitchell; Brian W Jack
Journal:  J Addict Med       Date:  2012-03       Impact factor: 3.702

7.  Drug use and problem drinking associated with primary care and emergency room utilization in the US general population: data from the 2005 national alcohol survey.

Authors:  Cheryl J Cherpitel; Yu Ye
Journal:  Drug Alcohol Depend       Date:  2008-05-21       Impact factor: 4.492

8.  A randomized trial of cognitive behavioral therapy in primary care-based buprenorphine.

Authors:  David A Fiellin; Declan T Barry; Lynn E Sullivan; Christopher J Cutter; Brent A Moore; Patrick G O'Connor; Richard S Schottenfeld
Journal:  Am J Med       Date:  2013-01       Impact factor: 4.965

9.  Effect of a housing and case management program on emergency department visits and hospitalizations among chronically ill homeless adults: a randomized trial.

Authors:  Laura S Sadowski; Romina A Kee; Tyler J VanderWeele; David Buchanan
Journal:  JAMA       Date:  2009-05-06       Impact factor: 56.272

10.  An intervention to improve care and reduce costs for high-risk patients with frequent hospital admissions: a pilot study.

Authors:  Maria C Raven; Kelly M Doran; Shannon Kostrowski; Colleen C Gillespie; Brian D Elbel
Journal:  BMC Health Serv Res       Date:  2011-10-13       Impact factor: 2.655

View more
  13 in total

1.  Capsule Commentary on Wakeman et al., Effect of Integrating Substance Use Disorder Treatment into Primary Care on Inpatient and Emergency Department Utilization.

Authors:  Jared W Klein
Journal:  J Gen Intern Med       Date:  2019-06       Impact factor: 5.128

2.  Financing Buprenorphine Treatment in Primary Care: A Microsimulation Model.

Authors:  Jonathan E Fried; Sanjay Basu; Russell S Phillips; Bruce E Landon
Journal:  Ann Fam Med       Date:  2020-11       Impact factor: 5.166

3.  Data mining-based clinical profiles of substance use-related emergency department utilizers.

Authors:  Kristina Monti; Keren Bachi; Madeline Gray; Vibhor Mahajan; Gabrielle Sweeney; Anna M Oprescu; Kevin G Munjal; Yasmin L Hurd; Sabina Lim
Journal:  Am J Emerg Med       Date:  2021-12-30       Impact factor: 2.469

4.  Pharmacy-based methadone dispensing and drive time to methadone treatment in five states within the United States: A cross-sectional study.

Authors:  Paul J Joudrey; Nicholas Chadi; Payel Roy; Kenneth L Morford; Paxton Bach; Simeon Kimmel; Emily A Wang; Susan L Calcaterra
Journal:  Drug Alcohol Depend       Date:  2020-03-27       Impact factor: 4.492

5.  Impact of a Rapid-Access Ambulatory Psychiatry Encounter on Subsequent Emergency Department Utilization.

Authors:  David S Kroll; Karen Wrenn; John A Grimaldi; Lorna Campbell; Lisa Irwin; Maria Pires; Natalie Dattilo; Julia Schechter; Nomi Levy-Carrick; David F Gitlin
Journal:  Community Ment Health J       Date:  2020-08-17

6.  Adolescent and Adult Correlates of Prescription Opioid Use and Misuse in Adulthood: Associations Across Domains of Despair.

Authors:  Anna E Austin; Rebecca B Naumann; Mary C Figgatt; Allison E Aiello
Journal:  Subst Use Misuse       Date:  2021-01-06       Impact factor: 2.164

7.  Bridging the Gap: Dual Fellowship Training in Addiction Medicine and Digestive Diseases.

Authors:  Lamia Y Haque; David A Fiellin
Journal:  Dig Dis Sci       Date:  2022-04-16       Impact factor: 3.487

8.  Impact of Inpatient Addiction Consultation on Hospital Readmission.

Authors:  Sarah E Wakeman; Martha Kane; Elizabeth Powell; Sydney Howard; Christopher Shaw; Susan Regan
Journal:  J Gen Intern Med       Date:  2020-06-22       Impact factor: 6.473

9.  Feasibility and early experience of a novel multidisciplinary alcohol-associated liver disease clinic.

Authors:  Jessica L Mellinger; Gerald Scott Winder; Anne C Fernandez; Kristin Klevering; Amanda Johnson; Haila Asefah; Mary Figueroa; Jack Buchanan; Fred Blow; Anna S F Lok
Journal:  J Subst Abuse Treat       Date:  2021-04-09

10.  Evidence-Based Treatment of Young Adults With Substance Use Disorders.

Authors:  Scott E Hadland; Amy M Yule; Sharon J Levy; Eliza Hallett; Michael Silverstein; Sarah M Bagley
Journal:  Pediatrics       Date:  2021-01       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.